© Reuters. Ferrexpo says CSR partner could have ‘misappropriated’ funds

(Reuters) – Iron ore pellet producer Ferrexpo Plc (LON:) on Tuesday said some funds of a charity in Ukraine it donates to could have been “misappropriated” as indicated by findings of an ongoing independent investigation.

The Ukraine-focussed company said although the Independent Review Committee’s investigation – launched in February – into Blooming Land’s use of Ferrexpo’s funds was continuing, new evidence pointed to potential discrepancies.

The charity, which coordinates Ferrexpo’s Corporate Social Responsibility (CSR) programme, came under the scanner in 2018 after auditors found holes in the charity’s statements that showed how it uses the funds its receives.

Blooming Land did not immediately respond to a request for comment.

Ferrexpo said although auditors were unable to conclude how much control or influence its chief executive officer has over the charity, its board unanimously agreed that the top boss did not have significant influence or control.

Funding for Blooming Land’s CSR activities is provided solely by one of the company’s units in Ukraine and Khimreaktiv LLC, an entity ultimately controlled by Ukrainian mogul and Ferrexpo’s Chief Executive Officer and owner Kostyantin Zhevago.

Ferrexpo, which had delayed its full-year results twice as it awaited further progress of the review, reported a 13 percent drop in annual pretax profit on Tuesday. Revenue, however, rose 6.4 percent.

Ferrexpo shares were up marginally in early trading in London.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

READ  Boehringer Ingelheim plans to cut about 300 jobs in France

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Please enter your comment!
Please enter your name here